Journals / Anadolu Kardiyoloji Dergisi / 2011 / Cilt: 11 - Sayı: 2

EQ-5D akut koroner sendromlu hastalarda geçerli bir yaşam kalitesi ölçeği midir?

Is EQ-5D a valid quality of life instrument in patients with acute coronary syndrome?

Pages
156–162
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The correlation coefficients of the EQ-5D index score with the MacNew subscales ranged from 0.557 to 0.721, with EQ-5D VAS score ranging from 0.297 to 0.484 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the construct validity of the Turkish version of the EQ-5D in patients with acute coronary syndrome.
📊
Key Findings & Data:Methods: The study was conducted as a cross-sectional study at the Trakya University Hospital between February and May 2008.
💡
Conclusion & Impact:The correlation coefficients of the EQ-5D index score with the MacNew subscales ranged from 0.557 to 0.721, with EQ-5D VAS score ranging from 0.297 to 0.484 (p
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate the construct validity of the Turkish version of the EQ-5D in patients with acute coronary syndrome. Methods: The study was conducted as a cross-sectional study at the Trakya University Hospital between February and May 2008. All patients completed the Turkish version of the EQ-5D and MacNew heart-related quality of life scale. Construct validity of the EQ-5D was assessed according to relationships with MacNew subscales by using Spearman rank correlation and multiple linear regression analyses. Results: One hundred and twenty-two patients responded to the instruments. Mean age was 62.9±9.3 years and male gender (88 or 72.1%) was dominant. Mean score of the EQ-5D index was 0.79±0.32, while the global score of MacNew was 5.01±1.16. The correlation coefficients of the EQ-5D index score with the MacNew subscales ranged from 0.557 to 0.721, with EQ-5D VAS score ranging from 0.297 to 0.484 (p

Özet

Amaç: Çalışmanın amacı, akut koroner sendromlu hastalarda yaşam kalitesini ölçmek için EQ-5D genel yaşam kalite ölçeğinin Türkçe versiyonunun kullanılıp kullanılamayacağını belirlemektir. Yöntemler: Araştırma Şubat-Mayıs 2008 tarihleri arasında Trakya Üniversitesi Tıp Fakültesi Hastanesi Kardiyoloji servisi ve polikliniğinde akut koroner sendrom tanısı konulan 122 hasta üzerinde yürütülen kesitsel çalışmadır. Hastalardan elde edilen veriler EQ-5D genel yaşam kalite ölçeği, MacNew kalp hastalığına özgü yaşam kalite ölçeği ve demografik-klinik verileri kapsayan bir anket formu kullanılarak toplandı. EQ-5D ölçeğinin geçerliliği, MacNew kalp hastalığına özgü yaşam kalitesi ölçeğiyle ilişkisine göre Spearman korelasyon analizi ve çoklu doğrusal regresyon analizi kullanılarak değerlendirildi. Bulgular: Çalışmada kullanılan ölçekleri 122 hasta cevapladı. Hastaların yaş ortalaması 62.9±9.3 idi ve çoğunluğunu (88 veya %72.1) erkekler oluşturmaktaydı. EQ-5D indeks skor ortalaması 0.79±0.32, MacNew global skor ortalaması 5.01±1.16 olarak bulundu. MacNew kalp hastalığına özgü yaşam kalitesi ölçeğinin alt boyutları ve toplam skoru ile EQ-5D indeks skor arasında 0.557 ile 0.721 arasında değişen, EQ-5D VAS skor arasında 0.297 ile 0.484 arasında değişen pozitif yönde istatistiksel anlamlı (p

🔖

Cite This Article

SÜT, H. K., ÜNSAR, S. (2022). EQ-5D akut koroner sendromlu hastalarda geçerli bir yaşam kalitesi ölçeği midir?. Anadolu Kardiyoloji Dergisi, Cilt: 11 - Sayı: 2, 156–162. https://ajindex.com/articles/436700

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Ünsar S, Süt N, Durna Z. Health-related quality of life in patients with coronary artery disease. J Cardiovasc Nurs 2007; 22:501-7
  2. Onat A, Şansoy V, Soydan İ, Tokgözoğlu L, Adalet K. Heart health, risk profile and heart diseases of Turkish adults. Istanbul, Ohan; 2000
  3. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156: 1-10
  4. Onat A, Şenocak MS, Surdum-Avcı G, Örnek E. Prevalence of coronary artery disease in Turkish adults. Int J Cardiol 1993; 39: 23-31
  5. American Heart Association. Heart Disease and Stroke Statistics: 2008 Update At-a-Glance. 2008
  6. Prevalence of all coronary heart disease. Available at: URL: http:// www.heartstats.org/datapage.asp?id=1584 [Access date: 20 August 2009]
  7. Ellis JJ, Eagle KA, Kline-Rogers EM, Erickson SR. Validation of the EQ-5D in patients with a history of acute coronary syndrome. Curr Med Res Opin 2005; 21: 1209-16
  8. The EuroQoL Group. EuroQoL - a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208
  9. Daşkapan A, Hofer S, Oldridge N, Alkan N, Müderrisoğlu H, Tüzün EH. The validity and reliability of the Turkish version of the MacNew Heart Disease Questionnaire in patients with angina. J Eval Clin Pract 2008; 14: 209-13
  10. Schrag A, Selai C, Jahanshahi M, Quinn NP. The EQ-5D-a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 2000; 69: 67–73
  11. Fayers PM, Machin D. Quality of life - assessment, analysis & interpretation. Chichester:John Wiley & Sons Ltd.; 2000
  12. EQ-5D available versions. Available at: URL: http://www.euroqol.org/ web/users/ language_a.php. [Access date: 20 September 2007]
  13. MacNew Heart Disease Quality of Life Questionnaire. Available at: URL: www.macnew.org. [Access date: 28 September 2007]
  14. Oldridge N, Guyatt G, Jones N, Crowe J, Singer J, Feeny D, et al. Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction. Am J Cardiol 1991; 67: 1084-9
  15. Höfer S, Lim L, Guyatt GH, Oldridge N. The MacNew Heart Disease Health-related Quality of Life Instrument: a summary. Health Qual Life Outcomes 2004; 2: 3
  16. Schweikert B, Hahmann H, Leidl R. Validation of the EuroQol questionnaire in cardiac rehabilitation. Heart 2006; 92: 62-7. 17. van der Zanden BP, Dijkgraaf MGW, Blanken P, de Borgie CA, van Ree JM, van den Brink W. Validity of the EQ-5D as a generic he